WST

274.30

0.85% -2.36

Handel nachbörslich: 274.30

West Pharmaceutical Services Inc (WST)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt WST? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$276.66

Offen:

$276.19

24-Stunden-Volumen:

344.49K

Relative Volume:

0.49

Marktkapitalisierung:

$19.73B

Einnahmen:

$2.96B

Nettoeinkommen (Verlust:

$487.70M

KGV:

41.09

EPS:

6.6758

Netto-Cashflow:

$344.00M

1W Leistung:

+0.65%

1M Leistung:

-1.02%

6M Leistung:

+25.25%

1J Leistung:

-17.73%

1-Tages-Spanne:

$272.83

$277.50

1-Wochen-Bereich:

$270.02

$279.01

52-Wochen-Spanne:

$187.43

$348.90

West Pharmaceutical Services Inc Stock (WST) Company Profile

Firmenname

West Pharmaceutical Services Inc

Sektor

Healthcare (1131)

Branche

Medical Instruments & Supplies (58)

Telefon

(610) 594-2900

Adresse

530 HERMAN O. WEST DRIVE, EXTON, PA

Mitarbeiter

10,600

Twitter

@WestPharma

Nächster Verdiensttermin

2024-10-24

Neueste SEC-Einreichungen

WST's Discussions on Twitter

Vergleichen Sie WST mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
WST West Pharmaceutical Services Inc	274.30	19.90B	2.96B	487.70M	344.00M	6.6758
ISRG Intuitive Surgical Inc	577.81	204.60B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	196.33	55.88B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	80.38	39.38B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	244.76	35.68B	5.26B	1.44B	1.76B	9.7713
MDLN Medline Inc	44.13	34.85B	27.43B	1.27B	1.01B	1.5829

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-02	Eingeleitet	Morgan Stanley	Equal-Weight
2025-09-15	Eingeleitet	Rothschild & Co Redburn	Buy
2025-06-24	Eingeleitet	Barclays	Equal Weight
2025-03-18	Eingeleitet	Evercore ISI	Outperform
2025-02-14	Hochstufung	Deutsche Bank	Hold → Buy
2025-01-08	Eingeleitet	Citigroup	Buy
2024-12-13	Eingeleitet	Wolfe Research	Peer Perform
2024-12-12	Hochstufung	UBS	Neutral → Buy
2024-02-07	Hochstufung	Jefferies	Hold → Buy
2023-06-16	Hochstufung	BofA Securities	Neutral → Buy
2023-04-11	Hochstufung	Stephens	Equal-Weight → Overweight
2022-12-14	Eingeleitet	Deutsche Bank	Hold
2022-11-30	Eingeleitet	UBS	Neutral
2022-10-28	Herabstufung	BofA Securities	Buy → Neutral
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-10-14	Eingeleitet	Stephens	Equal-Weight
2020-07-21	Hochstufung	BofA Securities	Neutral → Buy
2020-04-24	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-12-12	Herabstufung	BofA/Merrill	Neutral → Underperform
2019-07-26	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-05-01	Herabstufung	Jefferies	Buy → Hold
2019-04-23	Eingeleitet	William Blair	Outperform
2018-04-25	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-01-24	Eingeleitet	Goldman	Neutral
2017-10-17	Herabstufung	BofA/Merrill	Buy → Neutral
2017-10-03	Eingeleitet	Stephens	Equal-Weight
2017-09-15	Hochstufung	Jefferies	Hold → Buy
2016-10-28	Hochstufung	Wells Fargo	Market Perform → Outperform
2016-09-21	Herabstufung	Wells Fargo	Outperform → Market Perform
2016-03-22	Eingeleitet	Wells Fargo	Outperform
2010-05-14	Bestätigt	UBS	Neutral
2010-02-23	Eingeleitet	Jefferies & Co	Buy
2008-12-19	Eingeleitet	UBS	Neutral

Alle ansehen

West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten

Dec 23, 2025

The Biotech Revolution’s Ultimate ‘Picks and Shovels’ Play: A Deep Dive into West Pharmaceutical Services (WST) - FinancialContent

Dec 23, 2025

Madrigal Heads to JPMorgan as MASH Drug Puts Company in the Spotlight - MyChesCo

Dec 23, 2025

Picks and Shovels of the Biotech Revolution: A Deep Dive into West Pharmaceutical Services (WST) - FinancialContent

Dec 23, 2025

West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Dec 23, 2025

Dec 22, 2025

Riverbridge Partners LLC Cuts Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat

Dec 22, 2025